midazolam eugia

Midazolam is a short-acting benzodiazepine that functions as a positive allosteric modulator of the GABA-A receptor. By binding to the benzodiazepine site of the receptor complex, it enhances the inhibitory effect of gamma-aminobutyric acid (GABA) by increasing the frequency of chloride channel opening, which leads to hyperpolarization of the neuron and subsequent sedative, anxiolytic, and anticonvulsant effects. The specific product **Midazolam Eugia**, manufactured by Eugia Pharma Specialities, has been utilized in clinical research led by the Universiteit Twente, most notably in the TELSTAR trial. This study investigated the efficacy of aggressive treatment for electroencephalographic status epilepticus in comatose patients following cardiac arrest, aiming to mitigate post-cardiac arrest brain injury and improve neurological recovery.

Brand names

Midazolam Eugia

Other names

midazolam